Susan Cohn
Director, Clinical Sciences · University of Chicago Medical Center
Credentials: · ·
History
Research
Review · The Lancet · 2007 · Last of 4 authors · 1,824 citations
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
Journal of Clinical Oncology · 2009 · First of 16 authors · Corresponding · 1,439 citations
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
New England Journal of Medicine · 2010 · 1,404 citations
51 papers
45 papers
44 papers
32 papers
30 papers
30 papers
24 papers
24 papers
Grants
- 2017–2022
The Institute for Translational Medicine
National Center for Advancing Translational Sciences · UL1
PI · $5.8M · University of Chicago
- 2013–2015
Mechanisms of Pancreatic Cancer Inhibition by SPARC
National Cancer Institute · R21
Contact PI · $372.9K · University of Chicago
- 2013–2015
Mechanism of SPARC Peptide FSEC Inhibition of Angiogenesis in Neuroblastoma
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $432.5K · University of Chicago
- 2004–2009
The Role of SPARC in Neuroblastoma Angiogenesis
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.2M · University of Chicago